INTRODUCTION
============

The spindle checkpoint is a cellular surveillance system that prevents premature sister-chromatid separation in mitosis and ensures the fidelity of chromosome segregation ([@B1]; [@B18]). It senses the existence of unattached kinetochores and kinetochores not under tension in a mitotic cell and inhibits the function of Cdc20, the mitotic activator of the anaphase-promoting complex or cyclosome (APC/C), thus stabilizing securin and cyclin B and delaying anaphase onset ([@B21]; [@B33]). On checkpoint activation, unattached kinetochores recruit checkpoint proteins in a hierarchical manner and promote their enzymatic and conformational activation, thus producing diffusible APC/C-inhibitory signals ([@B1]; [@B18]).

The mitotic checkpoint complex (MCC) consisting of BubR1 (Mad3 in yeast), Bub3, Mad2, and Cdc20 is a critical checkpoint inhibitor of APC/C ([@B24]; [@B25]; [@B32]). It inhibits APC/C by competitively blocking substrate binding and altering the mode of Cdc20 binding to APC/C ([@B2]; [@B8]; [@B4]; [@B7]). All four MCC components are enriched at unattached kinetochores, which promote MCC assembly in mitosis. MCC formation involves the conformational activation of Mad2, an unusual two-state protein that has two natively folded states, referred to as O-Mad2 (or N1-Mad2) and C-Mad2 (or N2-Mad2) ([@B3]; [@B10], [@B11], [@B12]; [@B13]; [@B16]; [@B17]; [@B30]). Cytosolic Mad2 adopts the O-Mad2 conformation. Unattached kinetochores recruit a Mad1--C-Mad2 core complex, which in turn recruits cytosolic O-Mad2 through O--C Mad2 dimerization. The loosely bound O-Mad2 undergoes conformational activation to become intermediate Mad2 (I-Mad2) or unliganded C-Mad2, which then binds to Cdc20. Binding of Mad2 to Cdc20 primes Cdc20 for BubR1--Bub3 binding, forming the MCC ([@B9]).

When all kinetochores achieve proper microtubule attachment and are under tension, the spindle checkpoint turns off to allow APC/C activation and chromosome segregation. Several mechanisms have been implicated in checkpoint inactivation in mammalian cells, including depletion of checkpoint proteins from attached kinetochores ([@B5]), capping of the Mad1--Mad2 core complex by the Mad2 inhibitor p31^comet^ ([@B15]; [@B31]), p31^comet^- and UbcH10-dependent Cdc20 autoubiquitination ([@B29]; [@B22]; [@B23]), and proteasomal degradation ([@B28]; [@B34]; [@B14]). The first two mechanisms regulate the kinetochore-mediated production of APC/C-inhibitory checkpoint complexes, including MCC, whereas the two latter mechanisms promote MCC disassembly. How these mechanisms are coordinated during checkpoint inactivation and mitotic exit is not understood. In particular, the role of Cdc20 autoubiquitination in checkpoint inactivation has remained controversial because preventing Cdc20 ubiquitination by mutating all lysines in Cdc20 to arginines does not prevent MCC disassembly ([@B19]).

In this study, we further investigate the roles and coordination of p31^comet^, proteasomal degradation, and Cdc20 ubiquitination in MCC disassembly and checkpoint inactivation. We show that both the proteasome and p31^comet^ are required for timely MCC disassembly in HeLa cells. Depletion of p31^comet^ by RNA interference (RNAi) further delays MCC disassembly in cells treated with the proteasome inhibitor MG132, suggesting that p31^comet^ has a proteasome-independent role in this process. Consistently, p31^comet^ depletion delays Mad2--Cdc20 dissociation and mitotic exit in cells expressing Cdc20 mutants deficient for autoubiquitination. Taken together, our results reconcile earlier conflicting data and suggest that p31^comet^ and Cdc20 ubiquitination act in somewhat redundant pathways to promote MCC disassembly and checkpoint inactivation.

RESULTS
=======

p31^comet^ is required for progression of unperturbed mitosis
-------------------------------------------------------------

We previously showed that depletion of p31^comet^ by RNAi in HeLa cells caused a delay in mitotic exit following the removal of nocodazole ([@B29]). To examine whether p31^comet^ was required for normal mitotic progression in the absence of spindle poisons, we performed time-lapse, live-cell imaging of HeLa cells treated with either a control small interfering RNA (siRNA) or siRNAs against p31^comet^. p31^comet^ siRNA1 and siRNA5 efficiently depleted p31^comet^ ([Figure 1A](#F1){ref-type="fig"}). Both were used in live-cell imaging experiments. Mitotic duration of each individual control- or p31^comet^-RNAi cell is shown in a waterfall plot ([Figure 1B](#F1){ref-type="fig"}). Representative images of cells at various time points of the time-lapse movies are shown in Supplemental Figure S1.

![p31^comet^ is required for proper mitotic progression. (A) Lysates of HeLa Tet-on cells transfected with control or p31^comet^ siRNAs were blotted with the indicated antibodies. APC2 and Mad2 were used as loading controls. (B) Waterfall plots showing the mitotic duration and fate of each individual HeLa cell transfected with control or p31^comet^ siRNAs. Mitotic duration is defined as the time between nuclear envelope breakdown (NEBD) and anaphase onset. (C) Duration from NEBD to the formation of a metaphase plate (metaphase) of cells transfected with the control or p31^comet^ siRNAs. Mean and SD are indicated. (D) Duration from metaphase to the onset of anaphase of cells transfected with the control or p31^comet^ siRNAs. Mean and SD are indicated.](4227fig1){#F1}

Depletion of p31^comet^ caused two phenotypes ([Figure 1B](#F1){ref-type="fig"}). In the case of p31^comet^ siRNA1, 27% of the p31^comet^ RNAi cells underwent a mitotic delay of 1.8 h on average and then died in mitosis. The rest of the p31^comet^ RNAi cells experienced a shorter mitotic delay of ∼40 min on average and then completed cell division normally ([Figure 1B](#F1){ref-type="fig"}). For the latter group of cells, the duration from nuclear envelope breakdown (NEBD) to metaphase was similar to that of the control cells ([Figure 1C](#F1){ref-type="fig"}). The delay in mitotic progression of these cells occurred at the metaphase--anaphase transition, that is, from the formation of a metaphase plate to the onset of chromosome segregation ([Figure 1D](#F1){ref-type="fig"}). Even for the first group of cells that eventually died in mitosis, ∼50% of those also exhibited discernible chromosome alignment at the metaphase plate. p31^comet^ siRNA5 caused a similar phenotype ([Figure 1B](#F1){ref-type="fig"}). These results indicate that p31^comet^ is required for the metaphase--anaphase transition during normal mitosis.

We used siRNA1 in subsequent experiments because ectopic expression of Myc-p31^comet^ resistant to siRNA1 rescued both the mitotic delay and cell death phenotypes caused by this siRNA (Supplemental Figure S2). We also note that a moderate mitotic delay does not necessarily trigger cell death. It is conceivable that p31^comet^ has a rather direct role in suppressing mitotic cell death.

MCC disassembly requires proteasome activity
--------------------------------------------

Recent studies implicated proteasomal degradation in checkpoint inactivation ([@B28]; [@B34]; [@B14]). To confirm the role of the proteasome in MCC disassembly, we released nocodazole-arrested HeLa cells into fresh medium with and without the proteasome inhibitor MG132 ([Figure 2](#F2){ref-type="fig"}). On the basis of fluorescence-activated cell sorting (FACS) analysis and immunoblotting of cell cycle markers, cells efficiently underwent mitotic exit in the absence of MG132 ([Figure 2, A and C](#F2){ref-type="fig"}). As expected, the amounts of Mad2 present in BubR1 immunoprecipitates dropped sharply within 1 h of release from nocodazole and reached basal levels at 2 h after release ([Figure 2D](#F2){ref-type="fig"}), indicating that MCC disassembled when cells exited from mitosis. By contrast, ∼70--80% of cells remained arrested in mitosis, with bipolar spindles and chromosomes aligned at the metaphase plate, at 4 h after the release from the nocodazole arrest into MG132-containing medium ([Figure 2B](#F2){ref-type="fig"}). Consistent with earlier findings ([@B28]; [@B34]; [@B14]), MCC persisted in cells arrested at metaphase by MG132 ([Figure 2D](#F2){ref-type="fig"}).

![The proteasome activity is required for MCC disassembly. (A) FACS analysis of nocodazole-arrested HeLa cells released into fresh medium with or without MG132 for indicated times. (B) Nocodazole-arrested cells or cells released into MG132-containing medium for 4 h were stained with 4′,6-diamidino-2-phenylindole (blue) or anti-tubulin (green). The percentage of cells with the indicated phenotypes is indicated. (C) Lysates of cells in A were blotted with the indicated antibodies. (D) Lysates of cells in A were immunoprecipitated with IgG or anti-BubR1. The immunoprecipitates were blotted with the indicated antibodies. (E) APC/C was immunoprecipitated from nocodazole-arrested HeLa cells released into fresh medium with or without MG132 for indicated times and assayed for ligase activity.](4227fig2){#F2}

We next tested whether APC/C^Cdc20^ was active in MG132-arrested cells. APC/C isolated from nocodazole-arrested HeLa cells had basal level activity ([Figure 2E](#F2){ref-type="fig"}). APC/C became more active at 2 h after release from nocodazole, concurrent with the completion of MCC disassembly ([Figure 2, D and E](#F2){ref-type="fig"}). By contrast, APC/C in cells arrested by MG132 exhibited only basal level activity similar to that of nocodazole-arrested cells ([Figure 2E](#F2){ref-type="fig"}). Therefore, despite apparent chromosome alignment, MCC still existed and APC/C remained inactive in MG132-arrested HeLa cells, indicating that the spindle checkpoint was not silenced in these cells. The levels of Cdc20, cyclin A2, cyclin B1, and securin were higher in MG132-treated cells ([Figure 2C](#F2){ref-type="fig"}). Thus APC/C ubiquitinated its substrates and targeted them for degradation at a basal rate even when the checkpoint was on.

It was generally believed that cells arrested in mitosis by MG132 had silenced their spindle checkpoint and activated APC/C^Cdc20^. They were arrested in metaphase because MG132 prevented the proteasome-dependent degradation of securin and cyclin B1. Our findings now suggest that MCC disassembly and APC/C activation require proteasome-mediated protein degradation and create an important caveat in the interpretation of results obtained using MG132-arrested metaphase cells. Although MG132 can clearly be expected to arrest cells in metaphase by blocking the degradation of securin and cyclin B1 independent of the spindle checkpoint, it also blocks MCC disassembly and some aspects of checkpoint inactivation.

p31^comet^ promotes Mad2 dissociation from Cdc20 even when the proteasome is inhibited
--------------------------------------------------------------------------------------

Both proteasome and p31^comet^ are required for timely checkpoint inactivation. We next wanted to examine the relationship between the two in this process. p31^comet^ has been proposed to play two roles in checkpoint inactivation (see also later discussion of [Figure 6](#F6){ref-type="fig"}). First, it caps the Mad1--Mad2 core complex and prevents Mad2 conformational activation, thus limiting the production of MCC. Second, it binds to Cdc20-bound Mad2, stimulating APC/C activity and promoting MCC disassembly. To separate the two roles of p31^comet^, we used the Aurora B inhibitor ZM447439 (referred to as ZM hereafter) to block the kinetochore-dependent pathway of MCC production in Taxol-arrested mitotic cells and investigated the fate of the existing MCC.

![p31^comet^ depletion delays MCC disassembly even with the proteasome inhibited. (A) FACS analysis of HeLa Tet-on cells transfected with control or p31^comet^ siRNA and then treated with Taxol followed by Aurora B inhibition with ZM447439. The percentage of mitotic cells (cells that have 4N DNA content and are MPM2 positive) is shown for each sample. (B) HeLa Tet-on cells were either mock transfected or transfected with p31^comet^ siRNA1 and arrested in mitosis by Taxol. MG132 and ZM447439 were then added to the cells. Samples were taken at the indicated times following ZM447439 addition. Cell lysates and anti-Cdc20 immunoprecipitates were blotted with the indicated antibodies.](4227fig3){#F3}

![p31^comet^ depletion delays Mad2 dissociation from lysine-less Cdc20. (A) Mitotic indices of HeLa Tet-on cells stably expressing Myc-Cdc20 WT or K-less that were transfected with siCdc20 or siCdc20/si-p31^comet^ and then treated with Taxol followed by ZM addition for the indicated durations. Mitotic index is determined by FACS. Mean and SD from four independent experiments are shown. (B) HeLa Tet-on cells stably expressing Myc-Cdc20 WT or K-less were transfected with siCdc20 or siCdc20/si-p31^comet^ and then treated with Taxol followed by ZM addition for the indicated durations. Anti-Myc immunoprecipitate from these cell lysates was blotted with anti-Myc and anti-Mad2. The blots were analyzed with an Odyssey Infrared Imaging System. (C) Quantification of Mad2 intensity in the anti-Myc immunoprecipitate in B. The Mad2 intensity is normalized to that of time 0 for each sample. Mean and SD of four independent experiments are shown.](4227fig4){#F4}

![p31^comet^ depletion delays Mad2 dissociation from Cdc20^ΔIR^. (A) In vitro translated, ^35^S-labeled Myc-Cdc20 WT or ΔIR was incubated with *Xenopus* APC/C bound to anti-Cdc27 beads in the presence or absence of the ubiquitination reaction mixture. The reaction mixtures were resolved by SDS--PAGE and analyzed with a phosphoimager. (B) Myc-Cdc20^ΔIR^-expressing cells were mock transfected or transfected with siCdc20 and treated with or without Taxol. Cell lysates were blotted with anti-Cdc20. The bands of Myc-Cdc20^ΔIR^ and the endogenous Cdc20 are indicated. The mitotic indices of each sample as determined by FACS are shown below each lane. (C) Myc-Cdc20^ΔIR^--expressing cells depleted of Cdc20 alone or depleted of both Cdc20 and p31^comet^ were treated with Taxol and then ZM for the indicated durations. Mitotic index of these cells was determined by FACS and plotted. (D) Myc immunoprecipitate from lysates of cells described in C was blotted with the indicated antibodies. The blots were analyzed with an Odyssey Infrared Imaging System. (E) Quantification of BubR1 intensity in the anti-Myc immunoprecipitate in D. The BubR1 intensity is normalized to that of time 0 for each sample. (F) Quantification of Mad2 intensity in the anti-Myc immunoprecipitate in D. The Mad2 intensity is normalized to that of time 0 for each sample.](4227fig5){#F5}

![Model illustrating the dynamics of MCC formation and disassembly and the roles of p31^comet^, Cdc20 ubiquitination, and the proteasome. See *Discussion* for details.](4227fig6){#F6}

We first tested whether p31^comet^ was required for checkpoint inactivation in HeLa cells arrested in mitosis by Taxol and then treated with ZM. p31^comet^ depletion did not block mitotic exit induced by Aurora B inhibition ([Figure 3A](#F3){ref-type="fig"}). At 90 min after ZM addition, the majority of both control and p31^comet^ RNAi cells exited from mitosis. Fewer p31^comet^ siRNA cells arrested in mitosis in the presence of Taxol, due to higher incidences of cell death.

Next we examined the relative contributions of proteasome and p31^comet^ during checkpoint inactivation triggered by Aurora B inhibition. Addition of MG132 alone did not prevent Mad2 dissociation from Cdc20 ([Figure 3B](#F3){ref-type="fig"}). Thus proteasomal degradation was not the sole mechanism for MCC disassembly. During this short time window of ZM addition, BubR1 did not completely dissociate from Cdc20, suggesting that Mad2 dissociation from Cdc20 could occur prior to, and independently of, BubR1 dissociation. Depletion of p31^comet^ delayed Mad2 dissociation from Cdc20 in the presence of MG132 ([Figure 3B](#F3){ref-type="fig"}). Thus p31^comet^ has a function in MCC disassembly that is independent of proteasome activity.

p31^comet^ promotes Mad2 dissociation from lysine-less Cdc20
------------------------------------------------------------

Cdc20 autoubiquitination stimulated by p31^comet^ and UbcH10 had been proposed to mediate MCC disassembly ([@B22]; [@B23]). On the other hand, a Cdc20 mutant with all lysines mutated to arginine (referred to as Cdc20 K-less) was capable of dissociating from Mad2 and BubR1 during checkpoint inactivation induced by Aurora B inhibition ([@B19]). Furthermore, cells expressing Cdc20 K-less established, but failed to maintain, their spindle checkpoint and underwent mitotic exit in the presence of spindle poisons. These results called into question the requirement of Cdc20 ubiquitination in MCC disassembly and suggested that Cdc20 ubiquitination and possibly degradation were required for checkpoint maintenance.

Because p31^comet^ promoted Mad2 dissociation in the absence of proteasome activity, we tested whether p31^comet^ was involved in the observed Mad2 dissociation from Cdc20 K-less. We constructed HeLa cell lines that stably expressed siRNA-resistant Myc-Cdc20 wild type (WT) or K-less transgenes. Consistent with earlier findings ([@B19]; [@B6]), depletion of Cdc20 from HeLa cells by RNAi caused mitotic arrest (Supplemental Figure S3). Ectopic expression of either Myc-Cdc20 WT or K-less rescued this mitotic block, indicating that both Cdc20 WT and K-less supported mitotic progression. Consistent with the previous report ([@B19]), cells expressing Myc-Cdc20 K-less at levels lower than those of Myc-Cdc20 WT failed to maintain their spindle checkpoint and exited from mitosis after a transient mitotic delay of ∼2 h in the presence of Taxol (data not shown).

We then transfected these cells with Cdc20 siRNA alone or both Cdc20 and p31^comet^ siRNAs, synchronized these cells at the G1/S boundary, released them into Taxol, and treated them with ZM to initiate checkpoint inactivation. As expected, p31^comet^ depletion from Myc-Cdc20 WT--expressing cells delayed mitotic exit by ∼30 min ([Figure 4A](#F4){ref-type="fig"}), as observed in parental HeLa cells. Fewer Myc-Cdc20 K-less--expressing cells accumulated in mitosis at the time of ZM addition, consistent with a defect in checkpoint maintenance ([Figure 4A](#F4){ref-type="fig"}). Addition of ZM greatly reduced the mitotic index of Cdc20 WT-- or K-less--expressing cells, indicating that the mitotic delay seen in these cells was checkpoint dependent. Depletion of p31^comet^ from Cdc20 K-less--expressing cells delayed mitotic exit following Aurora B inhibition ([Figure 4A](#F4){ref-type="fig"}). On the basis of quantitative Western blotting, depletion of p31^comet^ also delayed Mad2 dissociation from Myc-Cdc20 K-less ([Figure 4, B and C](#F4){ref-type="fig"}). These results indicate that p31^comet^ can promote mitotic exit and Mad2 dissociation from Cdc20, independently of Cdc20 ubiquitination. Of interest, compared with Myc-Cdc20 WT cells, depletion of p31^comet^ from Cdc20 K-less--expressing cells had apparently a greater effect on the kinetics of mitotic exit and MCC disassembly ([Figure 4](#F4){ref-type="fig"}). It is possible that, in the absence of Cdc20 autoubiquitination, the p31^comet^-dependent MCC disassembly pathway becomes particularly active.

p31^comet^ promotes Mad2 dissociation from a Cdc20 mutant deficient for autoubiquitination
------------------------------------------------------------------------------------------

Cells expressing Cdc20 K-less cannot maintain mitotic arrest in the presence of Taxol. Furthermore, p31^comet^ depletion delays both mitotic exit and Mad2 dissociation from Cdc20 K-less in these cells. It is formally possible that the delay in Mad2 dissociation from Cdc20 is a consequence of the delay in mitotic exit, not a direct effect of p31^comet^ inactivation. To circumvent these two caveats, we constructed another Cdc20 mutant that was deficient for autoubiquitination. The C-terminal IR motif of Cdc20 is critical for Cdc20 to bind and activate APC/C. Indeed, the Cdc20 mutant with its C-terminal IR motif deleted (Cdc20^ΔIR^) did not undergo efficient autoubiquitination in vitro ([Figure 5A](#F5){ref-type="fig"}). We next created HeLa Tet-on cell lines that stably expressed Myc-Cdc20^ΔIR^ at levels severalfold higher than that of endogenous Cdc20 ([Figure 5B](#F5){ref-type="fig"}). As expected, depletion of Cdc20 caused mitotic arrest of Cdc20^ΔIR^-expressing cells ([Figure 5B](#F5){ref-type="fig"}), as Cdc20^ΔIR^ could not bind to APC/C and was thus inactive. More important, inhibition of Aurora B by ZM did not trigger mitotic exit in Myc-Cdc20^ΔIR^--expressing cells depleted of Cdc20 alone or of both p31^comet^ and Cdc20, indicating that this mitotic arrest was independent of Aurora B ([Figure 5C](#F5){ref-type="fig"}). We next performed Myc immunoprecipitation from these cell lysates and blotted the immunoprecipitate with anti-Mad2 and anti-BubR1. Again, BubR1 did not completely dissociate from Cdc20^ΔIR^ during this short time window of ZM addition ([Figure 5, C and D](#F5){ref-type="fig"}). Depletion of p31^comet^ did not appreciably alter the partial BubR1 dissociation from Cdc20^ΔIR^. By contrast, the majority of Mad2 dissociated from Cdc20^ΔIR^ within 40 min of ZM addition. Depletion of p31^comet^ significantly delayed Mad2 dissociation from Cdc20^ΔIR^. Therefore, these results suggest that p31^comet^ can promote Mad2 dissociation from Cdc20 independent of Cdc20 autoubiquitination. In these experiments with Cdc20^ΔIR^-expressing cells, the cells are arrested in mitosis in a checkpoint-independent manner through Cdc20 RNAi, thus eliminating the two aforementioned caveats associated with Cdc20 K-less--expressing cells.

DISCUSSION
==========

Redundant functions of p31^comet^ and Cdc20 autoubiquitination in checkpoint inactivation
-----------------------------------------------------------------------------------------

Recently, extensive efforts have led to the discovery of multiple mechanisms for checkpoint inactivation and MCC disassembly and have greatly advanced our molecular understanding of these processes. The coordination and cross-talk among the multiple checkpoint inactivation mechanisms are poorly understood, however. In particular, a key unresolved controversy in the field is the role of Cdc20 autoubiquitination in checkpoint silencing.

[@B20]) first showed that Cdc20 underwent APC/C-dependent autoubiquitination and degradation during mitosis in yeast. This degradation required Mad2 and Mad3 (the yeast orthologue of BubR1), indicating that Cdc20 was ubiquitinated when it was bound to APC/C as part of the MCC. This mechanism was shown to be important for checkpoint-mediated inhibition of APC/C. Two related studies then showed that Cdc20 autoubiquitination was conserved in human cells, was stimulated by UbcH10 and p31^comet^, and was critical for MCC disassembly and checkpoint inactivation ([@B22]; [@B23]).

The role of Cdc20 autoubiquitination in checkpoint inactivation was later called into question, however. [@B19]) constructed a lysine-less Cdc20 mutant (Cdc20 K-less) that could not be ubiquitinated and showed that cells expressing this mutant established, but could not maintain, their spindle checkpoint in the presence of spindle poisons, consistent with Cdc20 ubiquitination being an APC/C-inhibitory checkpoint mechanism. Of interest, MCC containing Cdc20 K-less efficiently disassembled during checkpoint inactivation, leading Nilsson *et al*. to conclude that Cdc20 ubiquitination was not required for checkpoint inactivation.

In this study, we showed that p31^comet^ is required for proper mitotic progression and for timely checkpoint inactivation in the absence of spindle poisons. The proteasome activity is required for MCC disassembly and APC/C activation following the recovery from nocodazole-mediated mitotic arrest. More important, we showed that p31^comet^ depletion further delays MCC disassembly and checkpoint inactivation, even in the presence of proteasome inhibitors. Consistently, p31^comet^ delays Mad2 dissociation from Cdc20 K-less and ΔIR (another Cdc20 mutant deficient for autoubiquitination) during checkpoint inactivation. Therefore, although p31^comet^ can stimulate Cdc20 autoubiquitination and degradation, it has an additional function in promoting MCC disassembly that is independent of proteasomal degradation and Cdc20 ubiquitination.

We propose that p31^comet^ and Cdc20 autoubiquitination act in partially redundant pathways to promote MCC disassembly and checkpoint inactivation ([Figure 6](#F6){ref-type="fig"}). In this model, upon checkpoint activation, Cdc20 and the checkpoint proteins are recruited to unattached kinetochores in an Aurora B--dependent manner, enabling the conformational activation of Mad2 and increasing the rate of MCC formation (r~1~). Meanwhile, p31^comet^ selectively binds to the Cdc20-bound, active conformer of Mad2 and, along with UbcH10, stimulates Cdc20 autoubiquitination and degradation (r~2~). Because Cdc20 bridges the interaction between BubR1 and Mad2, degradation of Cdc20 is expected to cause the complete disassembly of MCC. In a separate pathway, p31^comet^, together with unknown factors, promotes MCC disassembly (r~3~), independent of Cdc20 ubiquitination and degradation, creating free Cdc20. Finally, cap-independent, mitotic translation produces newly synthesized Cdc20 (r~4~). When the checkpoint is on, the rate of MCC formation is greater than the sum of the rates of MCC disassembly (i.e., r~1~ \> r~2~ + r~3~), resulting in MCC accumulation ([Figure 6](#F6){ref-type="fig"}).

Microtubule attachment during normal mitotic progression or inhibition of Aurora B by ZM447439 decreases the concentrations of checkpoint proteins at kinetochores, which is expected to reduce the rate of MCC formation. p31^comet^ caps the Mad1--Mad2 core complex and blocks the conformational activation of Mad2, but p31^comet^ binding to Mad1--Mad2 core complex does not appear to be regulated by the spindle checkpoint or Aurora B (data not shown). It likely acts as a constitutive mechanism to limit the rate of MCC formation. When the rate of MCC disassembly exceeds that of MCC formation (i.e., r~2~ + r~3~ \> r~1~), the steady-state level of MCC drops. In addition, the sum of the rate of Cdc20 synthesis and the rate of nondegradative MCC disassembly is greater than that of MCC formation (i.e., r~3~ + r~4~ \> r~1~), leading to an increase in the level of free Cdc20, APC/C activation, and checkpoint inactivation.

In the cases of Cdc20 K-less and ΔIR, although the pathway of Cdc20 autoubiquitination and degradation is blocked (i.e., r~2~ ≈ 0), the p31^comet^-dependent and Cdc20 ubiquitination-independent pathway (r~3~) is still on and can promote MCC disassembly and checkpoint inactivation. The underlying reasons for the inability of Cdc20 K-less--expressing cells to maintain the spindle checkpoint are unclear but could not simply be attributed to total Cdc20 levels. One possibility is that Cdc20 K-less--expressing cells accumulate active APC/C^Cdc20^ species.

In the cells treated with both MG132 and ZM, BubR1 dissociates from Cdc20 more slowly than Mad2 does ([Figure 3B](#F3){ref-type="fig"}). Furthermore, BubR1 does not completely dissociate from Cdc20^ΔIR^ in cells treated with ZM, and p31^comet^ does not impede this partial dissociation of BubR1 from Cdc20 ([Figure 5D](#F5){ref-type="fig"}). These findings suggest that Cdc20 autoubiquitination and the proteasome pathway might preferentially promote BubR1 dissociation from Cdc20. The proteasome-independent, p31^comet^-dependent pathway preferentially promotes Mad2 dissociation from Cdc20.

Why then does depletion of p31^comet^ only cause a transient mitotic delay and not completely block checkpoint inactivation? We envision three possibilities. First, there are other, unidentified p31^comet^-independent and proteasome-independent pathways for MCC disassembly checkpoint inactivation. Second, the Cdc20 autoubiquitination pathway is not strictly p31^comet^-dependent. The basal rates of Cdc20 autoubiquitination and degradation in the absence of p31^comet^ are sufficient to trigger MCC disassembly, albeit with a delay. Finally, trivial explanations, such as the incompleteness of p31^comet^ depletion, cannot be ruled out.

Nonetheless, our findings strongly suggest that p31^comet^ and Cdc20 autoubiquitination do not act in the same linear pathway. p31^comet^ has a role in MCC disassembly that is independent of Cdc20 ubiquitination and degradation, providing a straightforward explanation for the disassembly of MCC containing Cdc20 K-less or ΔIR.

Purified p31^comet^ is insufficient to promote the disassembly of recombinant MCC in vitro ([@B29]; data not shown), indicating that other factors are required. It is intriguing that Hershko and coworkers recently showed that p31^comet^-dependent MCC disassembly in HeLa cell extracts requires the hydrolysis of the β--γ bond of ATP but not the hydrolysis of the α--β bond ([@B27]). Because hydrolysis of the α--β bond of ATP is sufficient to support ubiquitination, their results are consistent with the notion that p31^comet^ has a role independent of Cdc20 ubiquitination in MCC disassembly. Identification of the ATP-dependent enzyme that cooperates with p31^comet^ to promote MCC disassembly is an important task for the future.

MCC as a dynamic entity in mitosis
----------------------------------

The steady-state levels of MCC are determined by the difference between the rate of MCC formation and the rate of disassembly. Three possible scenarios can explain the checkpoint-dependent accumulation of MCC in mitosis. In the first scenario, the rate of MCC formation increases during mitosis, whereas the rate of MCC disassembly remains constant during the cell cycle. In a second scenario, an increase in the rate of MCC formation during mitosis is accompanied by a concomitant drop in the rate of MCC disassembly. In a third scenario, both rates of MCC formation and disassembly increase during mitosis, with the former being greater than the latter. The fact that Cdc20 autoubiquitination requires Mad2 and BubR1 suggests the third scenario occurs in the cell. In other words, the spindle checkpoint elevates both the rates of MCC formation and disassembly.

Why then is the third scenario beneficial to the cell? The third scenario makes MCC a highly dynamic entity. As a consequence, the level of MCC is more responsive to the status of checkpoint signaling. Once all sister chromatids achieve proper attachment, MCC can quickly disassemble to allow APC/C activation and sister-chromatid separation. This scenario is reminiscent of elevated dynamic instability of microtubules during mitosis. By contrast, the first two scenarios produce a slower and undesirable process of MCC disassembly and checkpoint inactivation.

In summary, the current evidence indicates that MCC assembly and disassembly are highly dynamic processes in mitosis. The differences between the rates of multiple competing reactions determine the steady-state levels of MCC and active APC/C and hence influence the status of the spindle checkpoint. p31^comet^ and ubiquitination of Cdc20 function somewhat redundantly to promote checkpoint inactivation, ensuring robust and timely anaphase initiation.

MATERIALS AND METHODS
=====================

Cell culture and transfection
-----------------------------

HeLa Tet-on cells were maintained in DMEM (Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (Invitrogen) and 100 μg/ml penicillin and streptomycin (Invitrogen). To arrest cells at G1/S, cells were treated with 2.5 mM thymidine for 18 h. To arrest cells in mitosis, cells were treated with 100 nM Taxol or 330 nM nocodazole for 12--16 h.

The Cdc20 siRNA is Silencer Select Pre-designed siRNA (Ambion, Austin, TX) against Cdc20 (ID s2748) with the following sequence: sense strand, CGAAAUGACUAUUACCUGAtt; antisense strand, UCAGGUAAUAGUCAUUUCGga. The p31^comet^ siRNAs were synthesized by Dharmacon (Lafayette, CO) and have the following sequences: siRNA1, GGCUGCUGUCAGUUUACUUtt; siRNA2, GAAGAUUGGUUUCGACCCAtt; siRNA3, UUUAAAGGCUUCCGCGAGUtt; siRNA4, CGAAGAAACUCACGCCUCCtt; and siRNA5, GCACCGUCGUCAUGGCACAtt. Transfection of the siRNAs was performed with Lipofectamine RNAiMAX (Invitrogen) following manufacturer\'s instructions. An siRNA with the random sequence of GGCAUCUUAGCCCGUACUUtt was used as control. The final concentrations of siRNAs used in the transfections were 2--10 nM.

The Myc-Cdc20 WT, K-less, and ΔIR stable cell lines were made by transfecting HeLa Tet-on cells with pTRE2-Myc-Cdc20 WT, K-less, or ΔIR plasmids using Effectene transfection reagent (Qiagen, Valencia, CA). Resistant colonies were selected using 400 μg/ml hygromycin (Clontech, Mountain View, CA). Single colonies were picked and screened for inducible expression in the absence and presence of 1.5 μg/ml doxycycline (Clontech). For actual experiments, Myc-Cdc20 WT--expressing cells (clone 11) were cultured in the presence of doxycycline. Myc-Cdc20 ΔIR--expressing cells (clone 6) were also cultured in the presence of doxycycline. Myc-Cdc20 K-less--expressing cells (clone 9) were cultured in the absence of doxycycline to keep the expression levels of Cdc20 K-less low.

Antibodies, immunoblotting, and immunoprecipitation
---------------------------------------------------

Antibodies against BubR1, Cdc20, APC2, Mad2, and p31^comet^ were described previously ([@B25]; [@B29]). The mouse anti-Myc (9E10) antibody was purchased from Roche (Indianapolis, IN). For quantitative immunoblotting, anti--rabbit immunoglobulin G (IgG) (H+L) (Dylight 800 conjugates) and anti--mouse IgG (H+L) (Dylight 680 conjugates) (Cell Signaling, Beverly, MA) were used as secondary antibodies. The membranes were scanned with the Odyssey Infrared Imaging System (LI-COR, Lincoln, NE).

For immunoprecipitation, the cell pellets were lysed with lysis buffer (50 mM Tris-HCl, pH 7.7, 120 mM KCl, 0.1% NP40, 1 mM dithiothreitol) supplemented with protease inhibitor tablets (Sigma-Aldrich, St. Louis, MO). After centrifuging for 30 min at 4°C at top speed in a microcentrifuge, the supernatants were incubated with protein A beads coupled to anti-Myc antibody or other antibodies for 2 h at 4°C. After washing, the beads were boiled in SDS sample buffer and analyzed by SDS--PAGE, followed by immunoblotting.

Live-cell imaging
-----------------

For live-cell imaging, ∼25,000 HeLa Tet-on cells were seeded into each well of a four-well chambered coverglass. At 24 h after seeding, cells were transfected with the control siRNA, p31^comet^ siRNA1, or p31^comet^ siRNA5 at 5 nM concentration. At 36 h after siRNA transfection, live-cell imaging was performed with a DeltaVision microscope (Applied Precision, Issaquah, WA). For each sample, 10 fields were chosen at random. Differential interference contrast images were taken with a 40× objective lens at 4-min intervals for a total duration of 21 h. Four 5-um optical slices were acquired for each time point. Images were processed with ImageJ (National Institutes of Health, Bethesda, MD) and Photoshop (Adobe, San Jose, CA).

Flow cytometry
--------------

HeLa Tet-on cells or the Myc-Cdc20--expressing stable cell lines were transfected with p31^comet^ siRNA1 or both p31^comet^ siRNA1 and the Cdc20 siRNA. Thymidine was added at 6 h after transfection. The cells were released into fresh media after the 18-h thymidine treatment. At 7 h after release, Taxol was added for another 7 h before ZM447439 (Selleck Chemicals, Houston, TX) addition. Cells were harvested at different time points after adding ZM447439 and were fixed with 70% ethanol. Propidium iodide was used to stain DNA. To stain mitotic cells, fixed cells were incubated with anti--phospho-MPM2 antibody (Millipore, Billerica, MA) followed by Alexa Fluor 488 donkey anti--mouse secondary antibody (Invitrogen). Cells were analyzed by a flow cytometer, and the data were processed with FlowJo (FloJo, Ashland, OR).

APC/C ubiquitination assays
---------------------------

APC/C ubiquitination assays using *Xenopus* or human APC/C were performed essentially as described ([@B26]).
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APC/C

:   anaphase-promoting complex/cyclosome

Bub1/3

:   budding uninhibited by benomyl 1/3

FACS

:   fluorescence-activated cell sorting

Mad1--3

:   mitotic arrest deficiency 1--3

MCC

:   mitotic checkpoint complex

NEBD

:   nuclear envelope breakdown

RNAi

:   RNA interference

siRNA

:   small interfering RNA
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